Rod Mackenzie, Ph.d.

Chief Development Officer and Executive Vice President

Payal Sahni Becher

Executive Vice President, Chief Human Resources Officer

Sally Susman

Executive Vice President, Chief Corporate Affairs Officer

John Young

Group President, Chief Business Officer

Ronald E. Blaylock

Board Member

W. Don Cornwell

Board Member

Susan Desmond-hellmann, Md., M.p.h

Board Member

Joseph J. Echevarria

Board Member

Scott Gottlieb, M.d.

Board Member

Helen H. Hobbs, M.d.

Board Member

Susan Hockfield, Ph.d.

Board Member

James M. Kilts

Board Member

Dan R. Littman, M.d., Ph.d.

Board Member

Shantanu Narayen

Board Member

Suzanne Nora Johnson

Board Member

James Quincey

Board Member

James C. Smith

Board Member

Kendra K. Bence, Phd

( Internal Medicine, Metabolic Disease ) Senior Director, Metabolism

Morris J. Birnbaum, Md, Phd

( Internal Medicine, Metabolic Disease ) Senior Vice President and Chief Scientific Officer, Internal Medicine Research Unit

Albert Kim, Md, Phd

( Internal Medicine, Metabolic Disease ) Vice President, Clinical Research Head

Bei B Zhang

( Internal Medicine, Metabolic Disease ) Vice President, Metabolic Research

Jean Beebe, Phd

( Inflammation & Immunology ) Vice President, Clinical Portfolio Leader, I&I Research Unit

Jeremy D Gale, Phd

( Inflammation & Immunology ) Vice President and Clinical Portfolio Leader

Thomas A Wynn, Phd

( Inflammation & Immunology ) Vice President, Discovery

Jeff Settleman

( Oncology) Chief Scientific Officer

Kim T Arndt, Phd

( Oncology) Vice President, Oncology Scientific Strategy

Darrin M Beaupre Md, Phd

( Oncology) Senior Vice President, Head of Early Oncology Development and Clinical Research

Robert Rickert, Phd

( Oncology) SVP, Chief Scientific Officer, Cancer Immunology Discovery

Nicholas A Saccomano, Ph.d.

( Oncology) Chief Scientific Officer-SVP, Pfizer Boulder Research and Development

Seng H Cheng, Ph.d.

( Rare Disease ) Senior Vice President & Chief Scientific Officer

Katherine L Beaverson, Ms

( Rare Disease ) Senior Director, Patient Advocacy Lead

Michael Binks, Md

( Rare Disease ) Vice President of Clinical Research

Christian Czech, Ph.d

( Rare Disease ) heading the Pfizer research site in Nice, France and

I am the project leader of Recifercept, the asset acquired from Therachon

Sarah Grimwood, Ph.d.

( Rare Disease ) Chief of Staff and RDRU Scientific Affairs

Greg Larosa, Ph.d

( Rare Disease ) SVP and Head Scientific Research

John Murphy, Ph.d.

( Rare Disease ) Vice President, Discovery Biology

Clark Pan, Ph.d

( Rare Disease ) Vice President Gene Therapy

Nanette Cocero

( Vaccines ) Global President, Vaccines, Pfizer Biopharmaceuticals Group

William C. Gruber, M.d., Faap, Fidsa

( Vaccines ) Senior Vice President of Pfizer Vaccine Clinical Research and Development

Kathrin U. Jansen, Ph.d.

( Vaccines ) Senior Vice President, Head of Vaccine Research and Development

Dr. Luis Jodar

( Vaccines ) Chief Medical Officer

Nicholas Kitchin, Md

( Vaccines ) Senior Director

Mace L Rothenberg

( Medical Professionals ) Chief Medical Officer

Dara Richardson-heron, M.d.

Chief Patient Officer